カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のソマトスタチン薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Somatostatin Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19638）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19638
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：91
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のソマトスタチン薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ソマトスタチン薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のソマトスタチン薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ソマトスタチン薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・オクトレオチド、ランレオチド、パシレオチド、その他

用途別セグメントは次のように区分されます。
・病院、薬局、その他

世界のソマトスタチン薬市場の主要な市場プレーヤーは以下のとおりです。
・Novartis、Pfizer、Ispen、HYBIO、TianTaiShan

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ソマトスタチン薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なソマトスタチン薬メーカーの企業概要、2019年～2022年までのソマトスタチン薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なソマトスタチン薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ソマトスタチン薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのソマトスタチン薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのソマトスタチン薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびソマトスタチン薬の産業チェーンを掲載しています。
・第13、14、15章では、ソマトスタチン薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ソマトスタチン薬の概要
- 種類別分析（2017年vs2021年vs2028年）：オクトレオチド、ランレオチド、パシレオチド、その他
- 用途別分析（2017年vs2021年vs2028年）：病院、薬局、その他
- 世界のソマトスタチン薬市場規模・予測
- 世界のソマトスタチン薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Novartis、Pfizer、Ispen、HYBIO、TianTaiShan
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：オクトレオチド、ランレオチド、パシレオチド、その他
・用途別分析2017年-2028年：病院、薬局、その他
・ソマトスタチン薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ソマトスタチン薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ソマトスタチン薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ソマトスタチン薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ソマトスタチン薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Somatostatin Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Somatostatin Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Somatostatin Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Octreotide segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Somatostatin Drugs include Novartis, Pfizer, Ispen, HYBIO, and TianTaiShan, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Somatostatin Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Octreotide
Lanreotide
Pasireotide
Other
Market segment by Application can be divided into
Hospital
Pharmacy
Other
The key market players for global Somatostatin Drugs market are listed below:
Novartis
Pfizer
Ispen
HYBIO
TianTaiShan
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Somatostatin Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Somatostatin Drugs, with price, sales, revenue and global market share of Somatostatin Drugs from 2019 to 2022.
Chapter 3, the Somatostatin Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Somatostatin Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Somatostatin Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Somatostatin Drugs.
Chapter 13, 14, and 15, to describe Somatostatin Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Somatostatin Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Somatostatin Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Octreotide
1.2.3 Lanreotide
1.2.4 Pasireotide
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Somatostatin Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Somatostatin Drugs Market Size & Forecast
1.4.1 Global Somatostatin Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Somatostatin Drugs Sales in Volume (2017-2028)
1.4.3 Global Somatostatin Drugs Price (2017-2028)
1.5 Global Somatostatin Drugs Production Capacity Analysis
1.5.1 Global Somatostatin Drugs Total Production Capacity (2017-2028)
1.5.2 Global Somatostatin Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Somatostatin Drugs Market Drivers
1.6.2 Somatostatin Drugs Market Restraints
1.6.3 Somatostatin Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Somatostatin Drugs Product and Services
2.1.4 Novartis Somatostatin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Somatostatin Drugs Product and Services
2.2.4 Pfizer Somatostatin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Ispen
2.3.1 Ispen Details
2.3.2 Ispen Major Business
2.3.3 Ispen Somatostatin Drugs Product and Services
2.3.4 Ispen Somatostatin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 HYBIO
2.4.1 HYBIO Details
2.4.2 HYBIO Major Business
2.4.3 HYBIO Somatostatin Drugs Product and Services
2.4.4 HYBIO Somatostatin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 TianTaiShan
2.5.1 TianTaiShan Details
2.5.2 TianTaiShan Major Business
2.5.3 TianTaiShan Somatostatin Drugs Product and Services
2.5.4 TianTaiShan Somatostatin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Somatostatin Drugs Breakdown Data by Manufacturer
3.1 Global Somatostatin Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Somatostatin Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Somatostatin Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Somatostatin Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Somatostatin Drugs Manufacturer Market Share in 2021
3.5 Global Somatostatin Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Somatostatin Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Somatostatin Drugs Market Size by Region
4.1.1 Global Somatostatin Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Somatostatin Drugs Revenue by Region (2017-2028)
4.2 North America Somatostatin Drugs Revenue (2017-2028)
4.3 Europe Somatostatin Drugs Revenue (2017-2028)
4.4 Asia-Pacific Somatostatin Drugs Revenue (2017-2028)
4.5 South America Somatostatin Drugs Revenue (2017-2028)
4.6 Middle East and Africa Somatostatin Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Somatostatin Drugs Sales in Volume by Type (2017-2028)
5.2 Global Somatostatin Drugs Revenue by Type (2017-2028)
5.3 Global Somatostatin Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Somatostatin Drugs Sales in Volume by Application (2017-2028)
6.2 Global Somatostatin Drugs Revenue by Application (2017-2028)
6.3 Global Somatostatin Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Somatostatin Drugs Sales by Type (2017-2028)
7.2 North America Somatostatin Drugs Sales by Application (2017-2028)
7.3 North America Somatostatin Drugs Market Size by Country
7.3.1 North America Somatostatin Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Somatostatin Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Somatostatin Drugs Sales by Type (2017-2028)
8.2 Europe Somatostatin Drugs Sales by Application (2017-2028)
8.3 Europe Somatostatin Drugs Market Size by Country
8.3.1 Europe Somatostatin Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Somatostatin Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Somatostatin Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Somatostatin Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Somatostatin Drugs Market Size by Region
9.3.1 Asia-Pacific Somatostatin Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Somatostatin Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Somatostatin Drugs Sales by Type (2017-2028)
10.2 South America Somatostatin Drugs Sales by Application (2017-2028)
10.3 South America Somatostatin Drugs Market Size by Country
10.3.1 South America Somatostatin Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Somatostatin Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Somatostatin Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Somatostatin Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Somatostatin Drugs Market Size by Country
11.3.1 Middle East & Africa Somatostatin Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Somatostatin Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Somatostatin Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Somatostatin Drugs
12.3 Somatostatin Drugs Production Process
12.4 Somatostatin Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Somatostatin Drugs Typical Distributors
13.3 Somatostatin Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Somatostatin Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Somatostatin Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Somatostatin Drugs Product and Services
Table 6. Novartis Somatostatin Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Somatostatin Drugs Product and Services
Table 10. Pfizer Somatostatin Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Ispen Basic Information, Manufacturing Base and Competitors
Table 12. Ispen Major Business
Table 13. Ispen Somatostatin Drugs Product and Services
Table 14. Ispen Somatostatin Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. HYBIO Basic Information, Manufacturing Base and Competitors
Table 16. HYBIO Major Business
Table 17. HYBIO Somatostatin Drugs Product and Services
Table 18. HYBIO Somatostatin Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. TianTaiShan Basic Information, Manufacturing Base and Competitors
Table 20. TianTaiShan Major Business
Table 21. TianTaiShan Somatostatin Drugs Product and Services
Table 22. TianTaiShan Somatostatin Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Global Somatostatin Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 24. Global Somatostatin Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 25. Market Position of Manufacturers in Somatostatin Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 26. Global Somatostatin Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Somatostatin Drugs Production Site of Key Manufacturer
Table 28. Somatostatin Drugs New Entrant and Capacity Expansion Plans
Table 29. Somatostatin Drugs Mergers & Acquisitions in the Past Five Years
Table 30. Global Somatostatin Drugs Sales by Region (2017-2022) & (K Units)
Table 31. Global Somatostatin Drugs Sales by Region (2023-2028) & (K Units)
Table 32. Global Somatostatin Drugs Revenue by Region (2017-2022) & (USD Million)
Table 33. Global Somatostatin Drugs Revenue by Region (2023-2028) & (USD Million)
Table 34. Global Somatostatin Drugs Sales by Type (2017-2022) & (K Units)
Table 35. Global Somatostatin Drugs Sales by Type (2023-2028) & (K Units)
Table 36. Global Somatostatin Drugs Revenue by Type (2017-2022) & (USD Million)
Table 37. Global Somatostatin Drugs Revenue by Type (2023-2028) & (USD Million)
Table 38. Global Somatostatin Drugs Price by Type (2017-2022) & (USD/Unit)
Table 39. Global Somatostatin Drugs Price by Type (2023-2028) & (USD/Unit)
Table 40. Global Somatostatin Drugs Sales by Application (2017-2022) & (K Units)
Table 41. Global Somatostatin Drugs Sales by Application (2023-2028) & (K Units)
Table 42. Global Somatostatin Drugs Revenue by Application (2017-2022) & (USD Million)
Table 43. Global Somatostatin Drugs Revenue by Application (2023-2028) & (USD Million)
Table 44. Global Somatostatin Drugs Price by Application (2017-2022) & (USD/Unit)
Table 45. Global Somatostatin Drugs Price by Application (2023-2028) & (USD/Unit)
Table 46. North America Somatostatin Drugs Sales by Country (2017-2022) & (K Units)
Table 47. North America Somatostatin Drugs Sales by Country (2023-2028) & (K Units)
Table 48. North America Somatostatin Drugs Revenue by Country (2017-2022) & (USD Million)
Table 49. North America Somatostatin Drugs Revenue by Country (2023-2028) & (USD Million)
Table 50. North America Somatostatin Drugs Sales by Type (2017-2022) & (K Units)
Table 51. North America Somatostatin Drugs Sales by Type (2023-2028) & (K Units)
Table 52. North America Somatostatin Drugs Sales by Application (2017-2022) & (K Units)
Table 53. North America Somatostatin Drugs Sales by Application (2023-2028) & (K Units)
Table 54. Europe Somatostatin Drugs Sales by Country (2017-2022) & (K Units)
Table 55. Europe Somatostatin Drugs Sales by Country (2023-2028) & (K Units)
Table 56. Europe Somatostatin Drugs Revenue by Country (2017-2022) & (USD Million)
Table 57. Europe Somatostatin Drugs Revenue by Country (2023-2028) & (USD Million)
Table 58. Europe Somatostatin Drugs Sales by Type (2017-2022) & (K Units)
Table 59. Europe Somatostatin Drugs Sales by Type (2023-2028) & (K Units)
Table 60. Europe Somatostatin Drugs Sales by Application (2017-2022) & (K Units)
Table 61. Europe Somatostatin Drugs Sales by Application (2023-2028) & (K Units)
Table 62. Asia-Pacific Somatostatin Drugs Sales by Region (2017-2022) & (K Units)
Table 63. Asia-Pacific Somatostatin Drugs Sales by Region (2023-2028) & (K Units)
Table 64. Asia-Pacific Somatostatin Drugs Revenue by Region (2017-2022) & (USD Million)
Table 65. Asia-Pacific Somatostatin Drugs Revenue by Region (2023-2028) & (USD Million)
Table 66. Asia-Pacific Somatostatin Drugs Sales by Type (2017-2022) & (K Units)
Table 67. Asia-Pacific Somatostatin Drugs Sales by Type (2023-2028) & (K Units)
Table 68. Asia-Pacific Somatostatin Drugs Sales by Application (2017-2022) & (K Units)
Table 69. Asia-Pacific Somatostatin Drugs Sales by Application (2023-2028) & (K Units)
Table 70. South America Somatostatin Drugs Sales by Country (2017-2022) & (K Units)
Table 71. South America Somatostatin Drugs Sales by Country (2023-2028) & (K Units)
Table 72. South America Somatostatin Drugs Revenue by Country (2017-2022) & (USD Million)
Table 73. South America Somatostatin Drugs Revenue by Country (2023-2028) & (USD Million)
Table 74. South America Somatostatin Drugs Sales by Type (2017-2022) & (K Units)
Table 75. South America Somatostatin Drugs Sales by Type (2023-2028) & (K Units)
Table 76. South America Somatostatin Drugs Sales by Application (2017-2022) & (K Units)
Table 77. South America Somatostatin Drugs Sales by Application (2023-2028) & (K Units)
Table 78. Middle East & Africa Somatostatin Drugs Sales by Region (2017-2022) & (K Units)
Table 79. Middle East & Africa Somatostatin Drugs Sales by Region (2023-2028) & (K Units)
Table 80. Middle East & Africa Somatostatin Drugs Revenue by Region (2017-2022) & (USD Million)
Table 81. Middle East & Africa Somatostatin Drugs Revenue by Region (2023-2028) & (USD Million)
Table 82. Middle East & Africa Somatostatin Drugs Sales by Type (2017-2022) & (K Units)
Table 83. Middle East & Africa Somatostatin Drugs Sales by Type (2023-2028) & (K Units)
Table 84. Middle East & Africa Somatostatin Drugs Sales by Application (2017-2022) & (K Units)
Table 85. Middle East & Africa Somatostatin Drugs Sales by Application (2023-2028) & (K Units)
Table 86. Somatostatin Drugs Raw Material
Table 87. Key Manufacturers of Somatostatin Drugs Raw Materials
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Somatostatin Drugs Typical Distributors
Table 91. Somatostatin Drugs Typical Customers
List of Figures
Figure 1. Somatostatin Drugs Picture
Figure 2. Global Somatostatin Drugs Revenue Market Share by Type in 2021
Figure 3. Octreotide
Figure 4. Lanreotide
Figure 5. Pasireotide
Figure 6. Other
Figure 7. Global Somatostatin Drugs Revenue Market Share by Application in 2021
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Other
Figure 11. Global Somatostatin Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Somatostatin Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Somatostatin Drugs Sales (2017-2028) & (K Units)
Figure 14. Global Somatostatin Drugs Price (2017-2028) & (USD/Unit)
Figure 15. Global Somatostatin Drugs Production Capacity (2017-2028) & (K Units)
Figure 16. Global Somatostatin Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Somatostatin Drugs Market Drivers
Figure 18. Somatostatin Drugs Market Restraints
Figure 19. Somatostatin Drugs Market Trends
Figure 20. Global Somatostatin Drugs Sales Market Share by Manufacturer in 2021
Figure 21. Global Somatostatin Drugs Revenue Market Share by Manufacturer in 2021
Figure 22. Somatostatin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Somatostatin Drugs Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Somatostatin Drugs Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Somatostatin Drugs Sales Market Share by Region (2017-2028)
Figure 26. Global Somatostatin Drugs Revenue Market Share by Region (2017-2028)
Figure 27. North America Somatostatin Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Europe Somatostatin Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Somatostatin Drugs Revenue (2017-2028) & (USD Million)
Figure 30. South America Somatostatin Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Somatostatin Drugs Revenue (2017-2028) & (USD Million)
Figure 32. Global Somatostatin Drugs Sales Market Share by Type (2017-2028)
Figure 33. Global Somatostatin Drugs Revenue Market Share by Type (2017-2028)
Figure 34. Global Somatostatin Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 35. Global Somatostatin Drugs Sales Market Share by Application (2017-2028)
Figure 36. Global Somatostatin Drugs Revenue Market Share by Application (2017-2028)
Figure 37. Global Somatostatin Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 38. North America Somatostatin Drugs Sales Market Share by Type (2017-2028)
Figure 39. North America Somatostatin Drugs Sales Market Share by Application (2017-2028)
Figure 40. North America Somatostatin Drugs Sales Market Share by Country (2017-2028)
Figure 41. North America Somatostatin Drugs Revenue Market Share by Country (2017-2028)
Figure 42. United States Somatostatin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Somatostatin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Somatostatin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Somatostatin Drugs Sales Market Share by Type (2017-2028)
Figure 46. Europe Somatostatin Drugs Sales Market Share by Application (2017-2028)
Figure 47. Europe Somatostatin Drugs Sales Market Share by Country (2017-2028)
Figure 48. Europe Somatostatin Drugs Revenue Market Share by Country (2017-2028)
Figure 49. Germany Somatostatin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Somatostatin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Somatostatin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Somatostatin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Somatostatin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Somatostatin Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Somatostatin Drugs Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Somatostatin Drugs Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Somatostatin Drugs Revenue Market Share by Region (2017-2028)
Figure 58. China Somatostatin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Somatostatin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Somatostatin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Somatostatin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Somatostatin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Somatostatin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Somatostatin Drugs Sales Market Share by Type (2017-2028)
Figure 65. South America Somatostatin Drugs Sales Market Share by Application (2017-2028)
Figure 66. South America Somatostatin Drugs Sales Market Share by Country (2017-2028)
Figure 67. South America Somatostatin Drugs Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Somatostatin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Somatostatin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Somatostatin Drugs Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Somatostatin Drugs Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Somatostatin Drugs Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Somatostatin Drugs Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Somatostatin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Somatostatin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Somatostatin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Somatostatin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Somatostatin Drugs in 2021
Figure 79. Manufacturing Process Analysis of Somatostatin Drugs
Figure 80. Somatostatin Drugs Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のソマトスタチン及びソマトスタチン類似体市場2022年：市場規模予測（～2028年）
  • 世界の酢酸ソマトスタチン市場2022年：市場規模予測（～2028年）
  • 世界のオシメルチニブ医薬品市場2022年：市場規模予測（～2028年）
  • 世界のエクセナチド薬物市場2022年：市場規模予測（～2028年）
  • 世界のペガスパルガーゼ薬物市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19638 )"世界のソマトスタチン薬市場2022年：市場規模予測（～2028年）" (英文：Global Somatostatin Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。